Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Italian (Borsa Italiana) Healthcare Sector Analysis

UpdatedDec 05, 2025
DataAggregated Company Financials
Companies18
  • 7D-2.0%
  • 3M-11.4%
  • 1Y-20.2%
  • YTD-19.6%

Over the last 7 days, the Healthcare industry has dropped 1.3%, driven by Recordati Industria Chimica e Farmaceutica declining 3.2%. The industry has fallen 20% in the last year. Looking forward, earnings are forecast to grow by 12% annually.

Sector Valuation and Performance

Has the Italian Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 05 Dec 2025€20.3b€8.8b€886.9m19.5x22.9x2.3x
Sun, 02 Nov 2025€22.2b€8.8b€886.0m21.6x25.1x2.5x
Tue, 30 Sep 2025€21.9b€8.7b€895.4m21x24.5x2.5x
Thu, 28 Aug 2025€23.2b€8.7b€902.9m19.8x25.7x2.7x
Sat, 26 Jul 2025€24.6b€8.6b€941.3m20.8x26.2x2.9x
Mon, 23 Jun 2025€23.9b€25.2b€985.5m20x24.3x1x
Wed, 21 May 2025€22.9b€25.2b€985.5m16.5x23.2x0.9x
Fri, 18 Apr 2025€21.4b€20.1b€908.1m18.3x23.6x1.1x
Sun, 16 Mar 2025€22.9b€19.6b€796.0m21.2x28.8x1.2x
Tue, 11 Feb 2025€25.8b€20.0b€828.0m24x31.2x1.3x
Thu, 09 Jan 2025€25.0b€8.0b€834.7m22.8x30x3.1x
Sat, 07 Dec 2024€24.6b€19.0b€1.4b19.2x17.2x1.3x
Mon, 04 Nov 2024€24.8b€18.9b€1.4b16.4x18.1x1.3x
Wed, 02 Oct 2024€25.0b€18.9b€1.4b17.1x18.2x1.3x
Fri, 30 Aug 2024€26.1b€18.9b€1.4b15.1x18.9x1.4x
Sun, 28 Jul 2024€26.0b€18.8b€1.4b17.1x18.8x1.4x
Tue, 25 Jun 2024€26.2b€18.8b€1.4b16.6x19x1.4x
Thu, 23 May 2024€26.1b€18.8b€1.4b17.4x18.9x1.4x
Sat, 20 Apr 2024€25.2b€18.7b€1.4b19.5x18.3x1.3x
Mon, 18 Mar 2024€28.3b€18.6b€1.4b20.8x20.3x1.5x
Wed, 14 Feb 2024€24.6b€18.6b€1.4b18.6x17.7x1.3x
Fri, 12 Jan 2024€24.8b€18.6b€1.4b18.2x17.9x1.3x
Sun, 10 Dec 2023€23.5b€18.6b€1.4b18.3x16.9x1.3x
Tue, 07 Nov 2023€22.6b€18.6b€1.4b16.9x16.1x1.2x
Thu, 05 Oct 2023€22.4b€17.3b€1.1b14.6x19.6x1.3x
Sat, 02 Sep 2023€23.8b€17.3b€1.1b16x20.9x1.4x
Mon, 31 Jul 2023€24.6b€7.7b€861.1m15.3x28.6x3.2x
Wed, 28 Jun 2023€23.8b€7.7b€822.5m17.7x29x3.1x
Fri, 26 May 2023€24.1b€7.7b€822.5m22.9x29.3x3.1x
Sun, 23 Apr 2023€24.1b€7.6b€826.9m21.2x29.1x3.2x
Tue, 21 Mar 2023€22.7b€7.6b€868.1m19x26.2x3x
Thu, 16 Feb 2023€23.9b€7.4b€886.1m24.6x27x3.2x
Sat, 14 Jan 2023€24.0b€7.4b€886.1m23.9x27.1x3.2x
Mon, 12 Dec 2022€24.4b€7.4b€886.1m22.3x27.5x3.3x
Price to Earnings Ratio

27.5x


Total Market Cap: €24.4bTotal Earnings: €886.1mTotal Revenue: €7.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Italian Healthcare Sector Price to Earnings3Y Average 22.9x202320242025
Current Industry PE
  • Investors are relatively neutral on the Italian Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 22.9x.
  • The 3-year average PS ratio of 2.0x is lower than the industry's current PS ratio of 2.3x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 5.9% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the Italian Healthcare sector?

IT Market0.35%
Healthcare-1.99%
Healthtech1.30%
Healthcare Services0.47%
Life Sciences-1.26%
Medical Equipment-1.54%
Biotech-2.04%
Pharma-3.21%
Industry PE
  • Investors are most optimistic about the Healthtech industry even though it's trading below its 3-year average PE ratio of 55.8x.
    • Analysts are expecting annual earnings growth of 24.9%, which is lower than the prior year's growth of 116.9% per year.
  • Investors are most pessimistic about the Life Sciences industry, which is trading below its 3-year average of 33.6x.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 25% over the next 5 years.
  • However this is lower than its past earnings growth rate of 117% per year.
  • In contrast, the Biotech industry is expected to see its earnings decline by 77% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
AMP Amplifon€13.420.6%
+€18.7m		-44.5%PE25.5x
ELN EL.En€12.921.4%
+€14.4m		4.4%PE19.5x
GPI GPI€17.121.3%
+€6.4m		51.2%PE31.2x
IMD I.M.D. International Medical Devices€1.499.6%
+€2.3m		16.4%PE19.2x
SVS Svas Biosana€8.481.0%
+€425.1k		24.7%PE6.7x

Latest News

DIA
€60.08
DiaSorin
7D
-2.2%
1Y
-42.6%

DIA: Medium Term Upside Will Persist Despite Near Term Market Caution

Analysts have lowered their price target for DiaSorin from €75.40 to €68. They cite updated market models and slightly reduced growth projections as the primary reasons for this downward revision.
GVS
€3.86
GVS
7D
-3.4%
1Y
-31.5%
AMP
€13.42
Amplifon
7D
0.6%
1Y
-44.5%

Is There Now An Opportunity In Amplifon S.p.A. (BIT:AMP)?

Nov 28
Is There Now An Opportunity In Amplifon S.p.A. (BIT:AMP)?
REC
€48.88
Recordati Industria Chimica e Farmaceutica
7D
-3.2%
1Y
-4.9%

REC: Margins Will Rise On Interim Dividend And Share Buyback Completion

Analysts have adjusted their price target for Recordati Industria Chimica e Farmaceutica slightly downward from €60.32 to €60.30. This reflects modest changes in revenue growth expectations and profit margin forecasts.
FF
€9.40
Fine Foods & Pharmaceuticals N.T.M
7D
-1.3%
1Y
21.8%
ELN
€12.92
EL.En
7D
1.4%
1Y
4.4%

ELN: Revenue Expansion And Margin Outlook Will Define Upcoming Year

Analysts have raised their price target for EL.En. from €12.37 to €13.03, citing improved expectations for revenue growth and profit margins. What's in the News EL.En. S.p.A. has issued earnings guidance for the full year 2025 (Key Developments) The company anticipates yearly revenue growth compared to 2024 (Key Developments) EL.En. aims to improve its EBIT for the upcoming year (Key Developments) Valuation Changes The consensus analyst price target has increased slightly from €12.37 to €13.03.
GHC
€5.43
Garofalo Health Care
7D
-0.5%
1Y
-3.4%

Garofalo Health Care's (BIT:GHC) Performance Is Even Better Than Its Earnings Suggest

Nov 23
Garofalo Health Care's (BIT:GHC) Performance Is Even Better Than Its Earnings Suggest
PHIL
€23.50
Philogen
7D
-2.1%
1Y
25.7%

PHIL: Share Buyback and Stable Financials Will Support Current Fair Value

Narrative Update on Philogen Analysts have maintained their price target for Philogen at €26.00. They cite continued confidence in the company’s outlook despite only minor adjustments to valuation inputs.
GPI
€17.12
GPI
7D
1.3%
1Y
51.2%
SVS
€8.48
Svas Biosana
7D
1.0%
1Y
24.7%
ARBS
€2.96
Arterra Bioscience
7D
-2.0%
1Y
51.8%
EUK
€0.70
EuKedos
7D
0.7%
1Y
-16.2%

Sentiment Still Eluding EuKedos S.p.A. (BIT:EUK)

Oct 22
Sentiment Still Eluding EuKedos S.p.A. (BIT:EUK)
IVN
€2.03
iVision Tech
7D
2.3%
1Y
2.5%
HI
€290.00
Health Italia
7D
0.3%
1Y
127.5%

Health Italia's (BIT:HI) Profits Appear To Have Quality Issues

Oct 05
Health Italia's (BIT:HI) Profits Appear To Have Quality Issues
IMD
€1.49
I.M.D. International Medical Devices
7D
9.6%
1Y
16.4%